Indoco Remedies Ltd share price logo

Indoco Remedies Ltd Share Price (INDOCO)

₹346.751.67%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Overview of Indoco Remedies Ltd

Key events for Indoco Remedies Ltd

  • Indoco Remedies Allots Equity Shares Under ESOP - 29 Mar, 2024

    Indoco Remedies has allotted 31,850 equity shares under ESOP on March 29, 2024. The paid-up capital of the company now stands at Rs. 18,43,64,410.

  • Indoco Remedies Subsidiary Commences Commercial Production - 25 Mar, 2024

    Warren Remedies Pvt Ltd, a subsidiary of Indoco Remedies, has started commercial production of pharmaceutical intermediates and APIs at its new facility in Aurangabad. The company's board also approved the purchase of land for expansion plans. Indoco Remedies stock closed at ₹337 on the NSE, up 0.18%.

  • Indoco Remedies to Expand with Land Purchase - 13 Mar, 2024

    Indoco Remedies' Committee of Executive Directors has approved the purchase of a 2,860.75 sqm land parcel at Mahal Industrial Estate in Mumbai Suburban from Saldanha Realty and Infrastructure LLP for expansion plans.

  • Indoco Remedies Acquires Land for Expansion Plans - 12 Mar, 2024

    Indoco Remedies is set to acquire land measuring 2,860.75 sqm in Mumbai Suburban from Saldanha Realty and Infrastructure LLP for expansion plans.

Analyst Rating for Indoco Remedies Ltd stock

based on 5 analysts

BUY
60.00%
Buy
20.00%
Hold
20.00%
Sell

Based on 5 analysts offering long term price targets for Indoco Remedies Ltd. An average target of ₹395.2

Source: S&P Global Market Intelligence

Indoco Remedies Ltd share Performance

  • ₹343.7
    ₹354.45
    ₹346.75
    downward going graph

    0.88%

    Downside

    Day's Volatility:3.10%

    Upside

    2.22%

    downward going graph
  • ₹306.4
    ₹415
    ₹346.75
    downward going graph

    11.64%

    Downside

    52 Weeks Volatility:31.32%

    Upside

    19.68%

    downward going graph
1 Month Return7.4 %
3 Month Return-9.67 %
1 Year Return5.36 %
Previous Close₹352.65
Open₹348.60
Volume60.96K
Upper Circuit-
Lower Circuit-
Market Cap₹3,250.81Cr

Indoco Remedies Ltd Company Information

Indoco Remedies Limited is a Mumbaibased pharmaceutical company established in 1947 and currently has a presence in 55 countries with a USD 166 million turnover. It mainly focuses on Formulations Finished Dosage Forms and Active Pharmaceutical Ingredients. It is presently active in therapeutic segments, including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and antifungal. It has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, and is supported by a state-of-the-art RD Centre. AC Nielsen ORGMARG market survey ranks Indoco first in stomatology, ninth in opthalmic and 12th in pediatric segments in terms of prescription generation. It has a marketing network of 1248 medical representatives. To further its goals, the company purchased remaining shares of Xtend Industrial Designers and Engineers in 2014, and acquired a Clinical Research Division from Piramal Enterprise in 2015. It likewise incorporated Indoco Remedies Singapore Pte Limited in 2015 and established a 100% subsidiary in Czech Republic in 2019. It has also launched 8 new products, 5 in Cardiac, 2 in Anti-diabetic and 1 in Dermatology. The company is further patent-recognised for products like Olopatadine, Gliclazide, Brinzolamide, Febuxostat, Rufinamide, Lacosamide, Tapentadol, Aminoindane compound and Pyrazole derivatives. It currently has 3 subsidiary companies under its fold, Xtend Industrial Designers and Engineers Pvt. Ltd., Indoco Remedies Czech sro and Indoco Remedies UK Limited.

Share Price: ₹346.75 per share as on 12 Apr, 2024 04:01 PM
Market Capitalisation: ₹3,250.81Cr as of today
Revenue: ₹458.75Cr as on December 2023 (Q4 23)
Net Profit: ₹15.56Cr as on December 2023 (Q4 23)
Listing date: 14 Jan, 2005
Chairperson Name: Suresh G Kare
OrganisationIndoco Remedies Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Indoco Remedies Ltd

Insights on Indoco Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 16.61% to 18.17% in Dec 2023 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, INDOCO stock has moved up by 15.7%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.59% to 1.69% in Dec 2023 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 91.0% return, outperforming this stock by 85.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 145.5% return, outperforming this stock by 129.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 58.74% of holdings in Dec 2023 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 486.16 Cr → 461.77 Cr (in ₹), with an average decrease of 5.0% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.88% to 20.00% in Dec 2023 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 35.08 Cr → 16.3 Cr (in ₹), with an average decrease of 53.5% per quarter

Indoco Remedies Ltd Valuation

Indoco Remedies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-705.32x)

April 24, 2019

Today (31.72x)

April 12, 2024

Industry (62.56x)

April 12, 2024

Highest (242.71x)

September 6, 2018

LowHigh

Indoco Remedies Ltd Mutual Fund Holdings

Funds Holdings
Quant Small Cap Fund Growth Option Direct PlanQuant Small Cap Fund Growth Option Direct Plan0.73%
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.2%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan0.85%
DSP Healthcare Fund Direct GrowthDSP Healthcare Fund Direct Growth2.36%
ICICI Prudential Smallcap Fund Direct Plan GrowthICICI Prudential Smallcap Fund Direct Plan Growth0.66%

Indoco Remedies Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
58.74%
0.00
Foreign Institutions
1.69%
6.31
Mutual Funds
18.17%
9.42
Retail Investors
20%
-8.59
Others
1.39%
18.24

Technicals of Indoco Remedies Ltd share

News & Events of Indoco Remedies Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Indoco Remedies Ltd shares.

Indoco Remedies Ltd (INDOCO) share price today is ₹346.75

Indoco Remedies Ltd is listed on NSE

Indoco Remedies Ltd is listed on BSE

  • Today’s highest price of Indoco Remedies Ltd is ₹354.45.
  • Today’s lowest price of Indoco Remedies Ltd is ₹343.7.

PE Ratio of Indoco Remedies Ltd is 31.72

PE ratio = Indoco Remedies Ltd Market price per share / Indoco Remedies Ltd Earnings per share

Today’s traded volume of Indoco Remedies Ltd(INDOCO) is 60.96K.

Today’s market capitalisation of Indoco Remedies Ltd(INDOCO) is ₹3250.81Cr.

Indoco Remedies Ltd(INDOCOPrice
52 Week High
₹415
52 Week Low
₹306.4

Indoco Remedies Ltd(INDOCO) share price is ₹346.75. It is down -16.45% from its 52 Week High price of ₹415

Indoco Remedies Ltd(INDOCO) share price is ₹346.75. It is up 13.17% from its 52 Week Low price of ₹306.4

Indoco Remedies Ltd(INDOCOReturns
1 Day Returns
-5.9%
1 Month Returns
7.4%
3 Month Returns
-9.67%
1 Year Returns
5.36%